These findings suggest that EEI could ameliorate HFD-induced insulin resistance and NAFLD via improving insulin signaling pathways, inflammatory response, lipogenesis, and fatty acid oxidation. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.